We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (23)
- Safety monitoring and information (11)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
116 result(s) found, displaying 61 to 70
-
-
GuidanceGuidance on how the Poisons Standard is amended and the processes that underpin scheduling policy
-
GuidanceRisk management plans for medicines and biologicals has been updated with new content, new Australia-Specific Annex and a new form.
-
PageInformation on colourings in medicines for topical and oral use.
-
PageThe Scheduling Policy Framework (Scheduling Policy) sets out the national policy for applying access restrictions on medicines and chemicals.
-
PageFind out about our clinical evaluation streams and the functions each unit provides.
-
PageThis information explains your responsibilities when obtaining Good Manufacturing Practice (GMP) clearance by any pathway, or by GMP certification following our inspection.
-
PageA code of practice for those involved in the design, selection and use of tamper-evident packaging.
-
PageInformation for sponsors on demonstrating stability of medicines under Australian conditions.
-
PageWe provide transparency of the prescription medicines registration process via the online publication of Australian Public Assessment Reports (AusPARs). Explore questions and answers about AusPARs.